ResearcherShandong UniversityNo recent work listed

Feng Li Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1166-9028; OpenAlex author ID A5100448965. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. Last author DOI 10.3389/fonc.2023.1149942 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenyi Guo · 1 shared paper, 2023 · strength 0.17
- Paper Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. DOI 10.3389/fonc.2023.1149942 ↗
Lei Wang · 1 shared paper, 2023 · strength 0.17
- Paper Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. DOI 10.3389/fonc.2023.1149942 ↗
Jianwei Xu · 1 shared paper, 2023 · strength 0.17
- Paper Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. DOI 10.3389/fonc.2023.1149942 ↗
Chengqing Li · 1 shared paper, 2023 · strength 0.17
- Paper Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. DOI 10.3389/fonc.2023.1149942 ↗
Zhiyao Fan · 1 shared paper, 2023 · strength 0.17
- Paper Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. DOI 10.3389/fonc.2023.1149942 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.